Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Meeting To Examine Human Behavior And The Threat Of Disease
As swine flu spread from Mexico to Texas and then fanned out farther in the United States, Americans began to alter their behavior. Families kept children home from school, postponed trips to the mall, and stayed home instead of eating out. In so doing, the American population may have inadvertently altered the behavior of the pathogen itself.
generic viagra online
Vitamin D May Have Key Role In Helping Brain Work Well In Later Life
[Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men
News of the day
Dodd: HELP Committee To Release Reform Bill Within Days
An initial version of health reform legislation could be available "in the next several days," Sen. Chris Dodd, D-Conn., a senior member of the Senate Health, Education, Labor and Pensions Committee, told Dow Jones Newswires. Dodd added that another Democrat had presented ""four or five" different versions of a public plan Wednesday," but that the committee had not yet ironed out those controversial details (Yoest, 6/3).
Endocrinology

NICE Welcomes Office For Life Sciences New Blueprint To Support Innovative Drugs

NICE today welcomed the Office for Life Sciences new Blueprint to support the life sciences industry, which will also improve patient access to innovative new drugs. Welcoming the Blueprint launch, Andrew Dillon Chief Executive of NICE said: "Securing a successful future for the life sciences industries is important for patients and the UK economy.The Innovation Pass is an opportunity for data to be gathered on potentially important new treatments. NICE has been involved in discussions about the Innovation Pass, and we are looking forward to continuing to play a key role in developing the pass." Mr Dillon continued: "NICE is committed to engaging constructively with the pharmaceutical industry and we are extending the access that companies have to us, as we appraise their products. Later this year, we will begin asking pharmaceutical and other life sciences companies, whose products we are evaluating, to make technical staff available to engage with our advisory Appraisal Committees. They will be able to respond to requests from committee chairs to clarify the data they have submitted and to point out any error of fact in the presentation of their data. We believe that this will give companies more confidence in the way NICE handles the evaluation of their products." NICE


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009